StockNews.com started coverage on shares of Xencor (NASDAQ:XNCR – Get Rating) in a report issued on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on XNCR. SVB Leerink reaffirmed an outperform rating on shares of Xencor in a research note on Thursday, February […]
Related Keywords
Bassili Dahiyat , , Xencor Inc , Lazard Asset Management , Jpmorgan Chase Co , Tower Research Capital , Quadrant Capital Group , Ef Hutton Acquisition Co , Cantor Fitzgerald , Get Rating , Moderate Buy , Capital Group , Research Capital , Forest Capital Management , Asset Management , Xencor Daily , Xencor , Nasdaq Xncr , Xncr , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.